[Federal Register Volume 74, Number 208 (Thursday, October 29, 2009)]
[Notices]
[Page 55868]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E9-26016]


=======================================================================
-----------------------------------------------------------------------

OFFICE OF NATIONAL DRUG CONTROL POLICY


Paperwork Reduction Act; Proposed Collection; Comment Request

AGENCY: Office of National Drug Control Policy.

ACTION: 60-Day notice.

-----------------------------------------------------------------------

SUMMARY: The Office of National Drug Control Policy (ONDCP) intends to 
submit the following information collection request to the Office of 
Management and Budget for review and approval. ONDCP seeks public 
comment.
    Abstract: ONDCP will conduct face-to-face interviews and acquire 
urine samples from booked arrestees to obtain information concerning 
drug use; drug and alcohol treatment; and, drug market participation 
and arrests. Participation is voluntary.
    Type of Information Collection: New Collection.
    Title: Arrestee Drug Abuse Monitoring (ADAM II) Program 
Questionnaire.
    Affected Public: Persons arrested and booked in one of 10 
preselected booking facilities in the United States in one of two, 2-
week data collection cycles spanning six months.
    Estimated Burden: ADAM II proposes 10 sites that each conduct two 
cycles of surveys from 250 arrestees per cycle. The total number of 
participants is 5,000. The average survey estimate is 20 minutes. Total 
burden estimate is 1,667 hours.
    Goals: ONDCP intends to obtain drug-use data that are directly 
comparable to data collected under the first three years of ADAM II 
(2007-2009) and the 2000-2003 National Institute of Justice sponsored 
Arrestee Drug Abuse Monitoring program; provide consistent data 
collection points to support statistical trend analysis for the use of 
heroin, cocaine, crack, marijuana and methamphetamine; monitor the 
spread or emergence of methamphetamine use; and, support ONDCP's 
efforts to estimate chronic drug use and examine drug market behaviors.
    Comment Request: Public comments should address whether the 
proposed data are proper for the functions of the agency; whether the 
information will have practical utility; the accuracy of ONDCP's 
estimate of the burden of the proposed collection of information, 
including the validity of the methodology and assumptions; the quality, 
utility, and clarity of the information to be collected; and, the 
burden on proposed respondents, including the use of appropriate 
automated, electronic, mechanical, or other technological collection 
techniques or other forms of information technology, such as electronic 
submission of responses. Comments will be accepted for sixty days.
    Contact: Robert L. Cohen, ONDCP, Research/Data Analysis, 750 17th 
Street 835, Washington, DC 20503; telephone (202) 395-5598; 
facsimile (202) 395-6562.

    Dated: October 23, 2009.
Daniel R. Petersen,
Deputy General Counsel.
[FR Doc. E9-26016 Filed 10-28-09; 8:45 am]
BILLING CODE 3180-02-P